ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,801,383 | -4.0% | 600,461 | +19.7% | 0.35% | +12.1% |
| Q2 2023 | $1,875,748 | +47.0% | 501,537 | +31.7% | 0.31% | +27.8% |
| Q1 2023 | $1,275,848 | -5.7% | 380,850 | +35.3% | 0.24% | -6.5% |
| Q4 2022 | $1,353,548 | -88.3% | 281,403 | -47.8% | 0.26% | -72.0% |
| Q2 2021 | $11,575,000 | -86.0% | 538,884 | -59.8% | 0.94% | -85.1% |
| Q1 2021 | $82,676,000 | +32.6% | 1,338,884 | -10.3% | 6.27% | +42.7% |
| Q4 2020 | $62,340,000 | – | 1,492,090 | – | 4.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |